Invention Grant
- Patent Title: Pyrazolyl ureas as kinase inhibitors
-
Application No.: US15849987Application Date: 2017-12-21
-
Publication No.: US10294216B2Publication Date: 2019-05-21
- Inventor: Alistair Ian Longshaw , Euan Alexander Fraser Fordyce , Stuart Thomas Onions , John King-Underwood , Jennifer Diane Venable , Iain Walters
- Applicant: RESPIVERT LIMITED
- Applicant Address: GB Buckinghamshire
- Assignee: RESPIVERT LIMITED
- Current Assignee: RESPIVERT LIMITED
- Current Assignee Address: GB Buckinghamshire
- Agency: McDermott Will & Emery LLP
- Main IPC: A61K31/4427
- IPC: A61K31/4427 ; C07D401/14 ; C07D409/14 ; A61K31/497 ; C07D401/12 ; A61K31/498 ; A61K31/5377 ; A61K31/541 ; A61K31/551 ; C07D413/14 ; C07D487/04 ; A61K9/00 ; A61K47/26
Abstract:
There are provided compounds of formula (I) shown below as defined in the specification which are p38 MAP kinase inhibitors for use as medicaments for the treatment inter alia of inflammatory diseases.
Public/Granted literature
- US20180118719A1 PYRAZOLYL UREAS AS KINASE INHIBITORS Public/Granted day:2018-05-03
Information query
IPC分类:
